BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4 AND Treatment
23753 results:

  • 1. Riluzole Reverses a Number of Undesirable Effects of Dexamethasone in Glioblastoma cells.
    Keul J; Sperling S; Rohde V; Mielke D; Ninkovic M
    Anticancer Res; 2024 May; 44(5):1829-1835. PubMed ID: 38677733
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Merkel cell carcinoma overlapping Bowen's disease: two cases report and literature review.
    Chen X; Song X; Huang H; Zhang L; Song Z; Yang X; Lei S; Zhai Z
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):217. PubMed ID: 38668799
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
    Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
    BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation.
    Banerjee D; Bagchi S; Liu Z; Chou HC; Xu M; Sun M; Aloisi S; Vaksman Z; Diskin SJ; Zimmerman M; Khan J; Gryder B; Thiele CJ
    Nat Commun; 2024 Apr; 15(1):3432. PubMed ID: 38653778
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prediction of High-Risk Neuroblastoma Among Neuroblastic tumors Using Radiomics Features Derived from Magnetic Resonance Imaging: A Pilot Study.
    Kim J; Choi YH; Yoon H; Lim HJ; Han JW; Lee MJ
    Yonsei Med J; 2024 May; 65(5):293-301. PubMed ID: 38653568
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study.
    Liu C; Kuang S; Huang T; Wu J; Zhang L; Gong X
    CNS Neurosci Ther; 2024 Apr; 30(4):e14730. PubMed ID: 38644565
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Therapeutic efficacy analysis of endoscopic combined with serological diagnosis strategy and endoscopic in G1 and G2 gastric neuroendocrine neoplasms].
    Li WY; Liu Y; Zhang YM; Dou LZ; He S; Ke Y; Liu XD; Liu YM; Wu HR; Wang GQ
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):326-334. PubMed ID: 38644268
    [No Abstract]    [Full Text] [Related]  

  • 8. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
    Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic significance of systemic inflammatory parameters in high-grade glial tumor patients: Two center experience.
    Oztep Eskici S; Yilmaz EB
    Medicine (Baltimore); 2024 Apr; 103(16):e37726. PubMed ID: 38640334
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Extracellular mixed histones are neurotoxic and modulate select neuroimmune responses of glial cells.
    Da Silva DE; Richards CM; McRae SA; Riar I; Yang SS; Zurfluh NE; Gibon J; Klegeris A
    PLoS One; 2024; 19(4):e0298748. PubMed ID: 38630734
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Utilization of sperm cryopreservation in patients with testicular cancer.
    Menzel V; Richter E; Helke C; Bürk BT; Erb HHH; Leike S; Borkowetz A; Thomas C; Baunacke M
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):201. PubMed ID: 38630148
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Skin Cancer Risk of Narrow-Band UV-B (TL-01) Phototherapy: A Multi-Center Registry Study with 4,815 Patients.
    Åkerla P; Pukkala E; Helminen M; Korhonen N; Karppinen T
    Acta Derm Venereol; 2024 Apr; 104():adv39927. PubMed ID: 38629891
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Could the mitotic count improve personalized prognosis in melanoma patients?
    Buja A; Rugge M; Cozzolino C; Dossi F; Zorzi M; Vecchiato A; de Luca G; Del Fiore P; Tropea S; dall'Olmo L; Rossi CR; Boccuzzo G; Mocellin S
    PLoS One; 2024; 19(4):e0302309. PubMed ID: 38626072
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Laser interstitial thermal therapy for recurrent glioblastomas: a systematic review and meta-analysis.
    Zhao X; Li R; Guo Y; Wan H; Zhou D
    Neurosurg Rev; 2024 Apr; 47(1):159. PubMed ID: 38625588
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Gene Expression Patterns Associated with Survival in Glioblastoma.
    Morrison C; Weterings E; Gravbrot N; Hammer M; Weinand M; Sanan A; Pandey R; Mahadevan D; Stea B
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612480
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine tumor (NF-PitNET) cells.
    Di Muro G; Catalano R; Treppiedi D; Barbieri AM; Mangili F; Marra G; Di Bari S; Esposito E; Nozza E; Lania AG; Ferrante E; Locatelli M; Modena D; Steinkuhler C; Peverelli E; Mantovani G
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612419
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeutics.
    Yang H; Li M; Deng Y; Wen H; Luo M; Zhang W
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23233. PubMed ID: 38607297
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).
    Atkins MB; Jegede OA; Haas NB; Mcdermott DF; Bilen MA; Stein M; Sosman J; Alter R; Plimack ER; Ornstein MC; Hurwitz M; Peace DJ; Einstein D; Catalano PJ; Hammers H; Regan MM
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604810
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The influence of rurality on melanoma diagnosis in Indiana: A retrospective cohort study.
    Xue GR; Clark M; Morr C; Slaven JE; Que SKT
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2072. PubMed ID: 38600393
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.
    Chen MF; Song Z; Yu HA; Sequist LV; Lovly CM; Mitchell EP; Moscow JA; Gray RJ; Wang V; McShane LM; Rubinstein LV; Patton DR; Williams PM; Hamilton SR; Umemura Y; Tricoli JV; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
    JCO Precis Oncol; 2024 Apr; 8():e2300454. PubMed ID: 38591867
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1188.